Retrospective analysis of cell-free fetal DNA prenatal testing of maternal peripheral blood.
10.3760/cma.j.cn511374-20220815-00545
- Author:
Youhua WEI
1
;
Rui WANG
;
Meixia XI
;
Li WEI
;
Wenjuan ZHU
;
Yan LIU
Author Information
1. Medical Genetics and Prenatal Screening Department, Maternity and Child Health Care Hospital of Zaozhuang, Zaozhuang, Shandong 277100, China. meixiaming@163.com.
- Publication Type:Journal Article
- MeSH:
Child;
Female;
Pregnancy;
Humans;
Retrospective Studies;
Cell-Free Nucleic Acids;
Chromosome Disorders/genetics*;
Prenatal Diagnosis/methods*;
Down Syndrome/genetics*;
Sex Chromosome Aberrations;
Trisomy 18 Syndrome/genetics*;
Trisomy 13 Syndrome/diagnosis*;
Aneuploidy;
DNA/genetics*;
Trisomy/genetics*
- From:
Chinese Journal of Medical Genetics
2023;40(8):933-938
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To assess the value of non-invasive prenatal testing (NIPT) for trisomy 21 (T21), trisomy 18 (T18), trisomy 13 (T13), sex chromosome aneuploidies, chromosomal microdeletions and microduplications using cell-free fetal DNA from peripheral blood samples of pregnant women.
METHODS:A total of 15 237 pregnant women who had undergone NIPT testing at the Maternity and Child Health Care Hospital of Zaozhuang from February 2015 to December 2021 were enrolled in this study. For those with a high risk by NIPT, amniotic fluid samples were collected for G-banding chromosomal karyotyping analysis and chromosomal microarray analysis to verify the consistency of NIPT with results of prenatal diagnosis. All of the women were followed up by telephone for pregnancy outcomes.
RESULTS:Among the 15 237 pregnant women, 266 (1.75%) were detected with a high risk for fetal chromosomal abnormality were detected. Among these, 79 (29.7%) were at a high risk for T21, 26 (9.77%) were at a high risk for T18, 9 (3.38%) were at a high risk for T13, 74 (27.82%) were at a high risk for sex chromosome aneuploidies, 12 (4.51%) were at a high risk for other autosomal aneuploidies, and 66 (24.81%) were at a high risk for chromosomal microdeletions or microduplications. 217 women had accepted invasive prenatal diagnosis and respectively 50, 13, 1, 25, 1 and 18 were confirmed with T21, T18, T13, sex chromosome aneuploidies, autosomal aneuploidies and microdeletions/microduplications, and the positive predictive values were 75.76%, 68.42%, 11.11%, 40.32%, 10% and 35.29%, respectively. For 13 042 women (85.59%), the outcome of pregnancy were successfully followed up. During the follow-up, one false negative case of T21 was discovered. No false positive cases for T13 and T18 were found.
CONCLUSION:NIPT has a sound performance for screening T13, T18 and T21, and is also valuable for screening other autosomal aneuploidies, sex chromosome aneuploidies and chromosomal microdeletions/microduplications.
